Page last updated: 2024-09-05
sb 216763 and helium
sb 216763 has been researched along with helium in 1 studies
Compound Research Comparison
| Studies (sb 216763) | Trials (sb 216763) | Recent Studies (post-2010) (sb 216763) | Studies (helium) | Trials (helium) | Recent Studies (post-2010) (helium) |
|---|---|---|---|---|---|
| 342 | 0 | 225 | 5,173 | 199 | 1,048 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Amour, J; Krolikowski, JG; Pagel, PS; Pratt, PF; Shim, YH; Warltier, DC; Weihrauch, D | 1 |
Other Studies
1 other study(ies) available for sb 216763 and helium
| Article | Year |
|---|---|
Inhibition of glycogen synthase kinase or the apoptotic protein p53 lowers the threshold of helium cardioprotection in vivo: the role of mitochondrial permeability transition.
Topics: Animals; Apoptosis; Atractyloside; Benzothiazoles; Cardiotonic Agents; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Glycogen Synthase Kinases; Helium; Indoles; Male; Maleimides; Mitochondria; Oxygen; Permeability; Rabbits; Toluene; Tumor Suppressor Protein p53 | 2008 |